(1R)-1-cyclobutylethan-1-amine hydrochloride is primarily used in pharmaceutical research and development as a chiral building block or intermediate in the synthesis of more complex molecules. Its stereochemistry makes it valuable for creating enantiomerically pure compounds, which are crucial in drug design to ensure specificity and reduce side effects. This compound may be utilized in the development of central nervous system (CNS) drugs, as its structure is compatible with targeting neurological receptors. Additionally, it can serve as a precursor in the synthesis of bioactive molecules, including potential treatments for psychiatric disorders or pain management. Its cyclobutyl group also offers unique conformational properties, making it useful in medicinal chemistry for exploring novel drug candidates with improved efficacy and stability.